TYPES OF APPLICATIONS

Initially, applications will be accepted for one fellowship to provide funding of 50,000 US dollars per year for three years. Indirect costs are not to exceed 8% and salary is not to exceed 35,000 US dollars including fringe benefits, with the remainder for supplies and/or equipment. 

ELIGIBILITY

Candidates must hold an M.D. or Ph.D. degree and have completed at least three years postdoctoral training but must be less than ten years post their first doctoral degree when the award begins. There are no restrictions based on nationality, but only one application will be considered from each sponsoring institution. Candidates must be committed to the research goals of the Foundation, must be able to devote at least 80% of their time to the project and must have a sponsoring institution with the academic environment to provide adequate support for the proposed project. 

SELECTION COMMITTEE

Application will be reviewed by the Scientific Advisory Committee of the Foundation. This Committee consists of internationally recognized leaders in the field of leukemic research. The decisions of the Committee are final and not subject to appeal. 

APPLICATION PROCEDURES

All applications must be typed, single spaced, in English and must follow the format specified in the attached application packet. All forms must be completed and space restrictions adhered to. Request for application fors will not be considered after October 15th. Application forms will not be sent by fax. Deadline for application receipt is November 1st 1996. Late applications will not be considered. Award announcements will be made by letter early in January. Do not contact the Foundation for results. Reapplication by unsuccessful candidates will be necessary for the following year. 

INCOMPLETE APPLICATIONS WILL NOT BE CONSIDERED. 8 complete sets (the original and 7 copies of the complete application-including all tables, illustrations and supporting materials) should be sent as follows: 

SPECIFIC INSTRUCTIONS

The following materials must be submitted: 

• Complete and signed application and forms 1 through 8.
• Current Curriculum Vitae and bibliography of applicant. C.V. must include name, birhtdate, social security number or other identifying number as applicable, citizenship, education, postdoctoral training and professional appointments, listed chronologically.
• Current Curriculum Vitae and selected bibliography of sponsor. (limit to two pages).
• Relevant reprints of applicant (limit of 4-5 )
• Letters of support from:
- sponsor
- two additional persons familiar with applicant's qualifications.
• Self-addressed, envelope or fax cover if you wish confirmation of receipt of application. Do not call the Foundation for confirmation.
• Refer to the checklist (Form 9). Be sure that all forms are complete, including required signatures. INCOMPLETE APPLICATIONS WILL NOT BE CONSIDERED.

• The awardee must notify the Foundation of any patent applications and the results of such application. Royalty Sharing will be determined by the Foundation, the awardee and the awardee's institution.
• The award is to be used solely for research as described in the proposal. Significant deviations resulting from research findings must be approved by the Scientific Advisory Committee. 
• If an awardee transfers to another institution prior written approval must be obtained to continue funding. Letters from the sponsor and three other persons with adequate knowledge of the project must be submitted at least 60 days prior to relocation. In addition two letters from the new institution must be submitted. These letters must describe the advantages and disadvantages for such relocation. Approval of the sponsoring institution must also be obtained to transfer any equipment purchased with funds from the Foundation. 
• The award may not be transferred to another individual. 
• All publications resulting from the research work must include a statement such as the following: "This research was funded (in part) by a grant (code nr............) from the Jose Carreras International Leukemia Foundation." Similar acknowledgement should be made for oral presentations and in press releases. 
• Payments will be made to the responsible financial officer of the awardee's institution. 
• The awardee will submit an annual progress report one month before the end of each year of the award. This report should describe specific goals achieved and outline future plans. An evaluation of the awardee's progress is also required from the awardee's sponsor. Copies of publications which have resulted from the work should also be provided. Failure to provide adequate reports will result in cancellation of the award. 
• The Foundation does not assume any legal or moral responsibility or obligation for the research or for the conduct of the recipient. All such responsibilitity remains with the awardee's sponsoring institution.